Atlas Trials

Pilot Study With GFT505 (80mg) in Patients Presenting With Impaired Glucose Tolerance and Abdominal Obesity.

Clinical trial NCT01275469 · COMPLETED

Trial details

NCT number
NCT01275469
Sponsor
Genfit
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Impaired Glucose ToleranceAbdominal Obesity
Start date
2009-06-01
Primary completion
2009-12-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.